The immediate-type allergic reaction is involved in many allergic diseases such as asthma, allergic rhinitis and sinusitis. In this study, we investigated the effect of acteoside extracted from Cistanche tubulosa (Schrenk) R. Wight on the basophilic cell-mediated allergic reaction.
type I allergy occurs within a few minutes and then mediators such as histamine and serotonin are released from the cell. The late phase reaction occurs hours after the early phase reaction in type I allergy, the mediators such as inflammatory cytokines TNF-α, IL-4, IL-6, IL-8, and IL-13 are secreted from the cells, respectively [14 -16] . β-Hexosaminidase, which is stored in the secretiory granules of mast cells is released concomitantly with histamine when mast cells are immunologically activated. Thus, β-hexosaminidase activity in the medium is used as a marker of mast cell degranulation [17] [18] . RBL-2H3 cells have been extensively used for studying IgE-FcεRI (the high affinity IgE receptor) interactions [19] , signaling pathways for degranulation [20] , and gene expression of inflammatory cytokines [21] . RBL-2H3 cells are therefore considered as a good tool for studying the effect of unknown compounds on histamine release or β-hexosaminidase release activity.
Basophils and mast cells types originate from the hematopoietic stem cells and share several biochemical and functional properties. Human mast cells are useful cells for studying synthesis of mediators and cytokine activation pathway because they secrete histamine and many inflammatory cytokines, when stimulated with phorbol esters and calcium ionophore A23187 [22] [23] . Both basophils and mast cells play a major role in the pathogenesis of inflammatory diseases by releasing several pro-inflammatory mediators [24] . Activated mast cells can produce histamine, as well as wide variety of other inflammatory mediators such as eicosanoids, proteoglycans, proteases and several proinflammatory and chemotactic cytokines such as TNF-α, IL-6, IL-4, IL-8, and IL-13. Therefore, modulation of secretion of these cytokines from mast cells can provide a useful therapeutic strategy for allergic inflammatory disease [23, 25] .
In this study, we investigated inhibition effect of three phenylethanoid glycosides derived from Cistanche tubulosa on β-hexosaminidase release by IgE-mediated RBL-2H3 cells as 7 type I allergy model, and inhibition effect of acteoside on histamine release from A23187 plus PMA or compound 48/80-stimulated KU812 cells, and on cytokines production by the same cell line.
Materials and methods

Cell lines, chemicals and biochemicals
RBL-2H3 cells were purchased from JCRB Cell Bank, Japan. The cells were maintained in MEM supplemented with 10%FBS and 2 mM L-glutamine, while KU812 cells were purchased from Riken Cell Bank, Japan. The cells were maintained in a RPMI 1640 medium supplemented with 10%FBS, and the cells incubated at 37 o C in a 5%CO 2 incubator.
Dinitrophenylated bovine serum albumin (DNP-BSA) was purchased from Cosmo Biotechnology Co., Ltd. Anti-DNP-IgE, ketotifen fumarate salt (>99%), L-glutamine, calcium ionophore A23187, PMA and compound 48/80 were purchased from Sigma-Aldrich.
Fetal bovine serum (FBS) was purchased from Hyclone Co., Ltd. Eagle's Minimum Essential Medium (MEM) was purchased from Nissui Pharmaceutical Co., Ltd.
3-[4,5-dimethylthiazolyl]-2,5-diphenyltetrazolium bromide (MTT) was purchased from Dojindo. Co., Ltd.
Plant material
The stems of Cistanche tubulosa (Orobanchaceae) were purchased from Shinwa Bussan Co., Ltd, in Osaka, Japan and identified by botany expert, and their voucher specimens (UT-CT040401) were deposited in the Graduate School of Life and Environmental Sciences, University of Tsukuba, Ibaraki, Japan.
Extraction and isolation
The stems of Cistanche tubulosa (500 g) were extracted with MeOH (1.5 l), and evaporated to dryness in vacuo at 30°C. The MeOH extract was partitioned between EtOAc 
MTT assay
The MTT assay is a sensitive and quantitative colorimetric assay that is used to determine cell viability [26] . RBL-2H3 cells and KU812 cells were harvested at approximately 60-80% confluence and seed onto 96-well plate at 5.0 × 10 4 cells/well in 100 µL medium. After an overnight incubation, the cells were washed twice with PBS (-) and 100 µL of medium with three phenylethanoid glycosides (0.1-100.0 µg/mL) was added. The cells were incubated for 48 h, before 10 µL of 5 mg/mL of MTT added. After 24 h of incubation, 180 µL of 10% 9 sodium dodecyl sulfate (SDS) was added, this being followed by another 24 h of incubation to completely dissolve the formazan produced by the cells. The absorbance was then determined at 570 nm with a microplate reader (Power Scan HT, Dainippon Pharmaceutical Co., Ltd.). Blanks were also prepared at the same treatment. The optical density of the formazan produced by the untreated control cells was considered as representing 100% viability.
β-Hexosaminidase release assay
The β-hexosaminidase release inhibition assay using RBL-2H3 cells was performed as previously described [26] . RBL-2H3 cells were seeded onto 96-well plates (Falcon Co.) at 5.0 × 10 4 cells/well in 100 µL of medium. The cells were incubated for 24 h at 37 o C and sensitized with 0.3 µg/mL anti-DNP-IgE, then washed twice with PBS (-) to eliminate free IgE. After incubating the cells at 37 o C for 10 min in 60 µL per well of a releasing mixture containing 5 µL of three phenylethanoid glycosides (0.1-10.0 µg/mL), the cells were exposed to 0.3 µg/mL DNP-BSA in PBS (-) followed by incubation at 37 o C for 1 h. For positive and negative controls, 3 mM ketotifen fumarate salt (Keto.) and PBS (-) were used, respectively.
Then, 80 µL of substrate solution was then added to 20 µL of the supernatant followed by incubation at 37 o C for 30 min. After adding 100 µL/well of stop buffer, the absorbance at 405 nm was obtained using a microplate reader. The percentage of β-hexosaminidase released was calculated using the following equation: 
Determination of intracellular [Ca 2+ ]i level
[Ca 2+ ]i measurement was performed by the method of Aase and Arna [27] with some modifications. RBL-2H3 cells (5.0×10 4 cells per well in 100 µL of medium) were and PBS (-) were used, respectively. The fluorescence intensity (FI) was determined 150 sec after adding 0.3 µg/mL of DNP-BSA antigen. FI was measured at an excitation wavelength of 490 nm and emission wavelength of 530 nm using a microplate reader.
Histamine release assay
The histamine release inhibition assay using KU812 cells was performed as previously described [28] and according to the method described by Hosoda et al. 
TNF-α and IL-4 production assay
The TNF-α and IL-4 production inhibition assay using KU812 cells was performed as previously described [28] . KU812 cells were seeded onto 96-well plates at 2.0 × 10 5 cells/well in 200 µL of medium, incubated with or without acteoside for 15 min and then stimulated with A23187 plus PMA for 16 h at 37 o C, 5%CO 2 incubator. The cells were separated from the secreted cytokine by centrifugation at 400 x g for 5 min at 4 o C. The supernatant (50 and 100 µL) was transferred to a 96-well ELISA system, and the TNF-α level and IL-4 concentration were determined by ELISA kit according to the manufacturer's instructions. Human TNF-α and IL-4 ELISA kit (Biosource International, USA) were used to detect TNF-α and IL-4, respectively. The absorbance at 450 nm was obtained using a microplate reader. To estimate the production of TNF-α or IL-4 by the cells, the same procedure was followed, but without the addition of A23187 plus PMA (Normal). Thus, the percentage of TNF-α or IL-4 production was calculated using the following equation. 
Statistical analysis
Our results are expressed as means ± SD. The statistical evaluation of the results was performed by one-way analysis of variance (ANOVA) followed by Duncan's post hoc test.
Results
We used the MTT assay to assess the cytotoxicity of three phenylethanoid glycosides on RBL-2H3 cells and KU812 cells. The cells were treated with three phenylethanoid for 48 h at final concentration of 0.1-100.0 µg/mL. As show in Fig. 2 , the tree phenylethanoid glycosides did not cause cytotoxicity at 0.1-10.0 µg/mL. But, the cell viability of the KU812 cells were decreased to 90% with the treatment of 100.0 μg/mL acteoside, and the effect being significant (p < 0.01, vs. the control value). Keto. (final 214 μM, IC 50 =200-300 μM) treatment (inhibition rate was 43.5%) (Fig. 2) .
To examine the relationship between β-hexosaminidase release and [Ca 2+ ]i levels in RBL-2H3 14 cells, we focusing on the acteoside which induced the highest inhibitory effect on β-hexosaminidase release, to determined the change in the [Ca 2+ ]i levels. The increase rate of the [Ca 2+ ]i level in IgE-mediated RBL-2H3 cells as affected by acteoside is shown in Fig. 4 .
Results reveal that after DNP-BSA stimulation, the cells showed a decrease in [Ca 2+ ]i level at each acteoside treatment (Fig. 4) . These result was suggest that acteoside suppressed [Ca 2+ ]i influx in the IgE-sensitized BSA-stimulated RBL-2H3 cells. The reduction of [Ca 2+ ]i levels with acteoside at 1.0-10.0 μg/mL treatment was higher than Keto. as positive control.
To investigate the inhibitory effect of acteoside on human basophilic cells, we examined A23187 plus PMA-or compound 48/ 80-induced KU812 cell activation. First of all, inhibitory effects of acteoside on A23187 plus PMA-induced KU812 cell degranulation were examined. Light microscopy photo showed that control KU812 cells generally are spherical or oval (Fig. 5A) . After stimulation with A23187 plus PMA, the cell became swollen and had many vacuoles and extruded granules near the cell surface and in the surrounding medium, which is interpreted as mast cell degranulation (Fig. 5B) . The cells became swollen with an irregular boundary, but the degranulation was reduced ( Figs. 5C and 5D ) by preincubation with acteoside in the A23187 plus PMA stimulated KU812 cells.
The inhibitory effects of acteoside on A23187 plus PMA-or compound 48/80-mediated histamine release from KU812 cells are shown in Fig. 6 . Acteoside dose-dependently inhibited A23187 plus PMA (Fig. 6A) -or compound 48/80 (Fig. 6B) 15 We examined whether acteoside could regulate inflammatory cytokines such as TNF-α and IL-4 in KU812 cells. The inhibition rate of TNF-α and IL-4 production in A23187 plus PMA-stimulated KU812 cells as affected by the acteoside is shown in Fig. 7 . The acteoside dose-dependently inhibited the production of TNF-α ( Fig. 7A) and IL-4 ( Fig. 7B) 
Discussion
In this study, phenylethanoid glycosides obtained from Cistanche tubulosa did not affect cell viability on RBL-2H3 cells and KU812 cells at the 1.0-10.0 µg/mL treatments. But, acteoside was cytotoxic at the 100.0 µg/mL treatments (Fig. 2B) , as has been reported by Saracoglu et al. [30] who have shown that acteoside isolated from Phlomic armeniaca and Scutellaria salviifolia showed cytotoxic effects on dRLh-84, S-180, P-388/D1 cell lines with the IC 50 30-221 µg/mL at different cell numbers. Our result was suggests that inhibition effect of actesoide on cell viability at 100 µg/mL treatment, maybe affected by its apoptotic activity.
The immediate-type allergic reaction is involved in many allergic diseases such as asthma, allergic rhinitis and sinusitis. Mast cells play a crucial role in inflammatory and immediate allergic responses. Our data shows that the acteoside has the highest inhibitory effect on the β-hexosaminidase release from IgE-sensitized, antigen-stimulated RBL-2H3 cells compared with other phenylethanoid glycosides at 1.0 μg/mL treatment (Fig. 3) . Inhibition effect of acteoside on β-hexosaminidase release at 10.0 μg/mL treatment was lower than that at 1.0 μg/mL treatment. As Sugisawa et al. [31] demonstrated, this may be contributed to H 2 O 2 induction at high concentrations of acteoside , which might regulated of calcium signals and degranulation on the RBL-2H3 cells [32] , influenced to β-hexosaminidase release at 10.0 μg/mL acteoside treatment.
The degranulation of mast cells is closely related to [Ca 2+ ]i. The inhibition of Ca 2+ influx by anti-allergic drugs plays a crucial role in the suppression of degranulation in mast cells.
[ [33] [34] . Our results indicate that the intracellular [Ca 2+ ]i level was lower in the acteoside-treated, DNP-BSA-stimulated RBL-2H3 cells (Fig. 4) , which is consistent with 17 other reports [34] [35] , and these results agree with those of Fig. 3 . We consider from these observations that the decrease in intracellular [Ca 2+ ]i is involved in the inhibitory effect of acteoside on β-hexosaminidase release. Nitric oxide (NO) and H 2 O 2 are two major reactive oxygen species (ROS) known in regulation of calcium signal and degranulation of mast cells.
ROS are necessary for secretion of β-hexosaminidase and calcium influx, and nicotinamide adenin dinucleotide phosphate (NADPH) oxidase is mainly responsible for ROS production in the IgE-mediated RBL-2H3 cells [29, 32] . The sustained elevation of cytosolic calcium through store-operated calcium entry was totally abolished when the ROS production was blocked. In addition, ROS have some relationship with ß-hexosaminidase and histamine release by protein kinase C (PKC) activation and IgE stimulation in RBL-2H3 cells [34] .
Furthermore, Suzuki et al. [36] found that there was a significant correlation between inhibition effects on histamine release and 1, 1-diphenyl-2-picry l-hydrazyl (DPPH) or superoxide anion radical scavenging activities of curcumin-related anti-oxidant compounds.
On the other hand, acteoside have free ragical scavenging properties on NO radical and DPPH radical [9, 37] . Also acteoside haw shown scavenging activity in activated human leucocytes [38] . One of the possibility that inhibition effect of acteoside on intracellular calcium release may be affected by its free radical scavenging activities or NADPH oxidase activities.
Acteoside dose-dependently inhibited histamine release on A23187 plus PMA-stimulated KU812 cell (Fig. 4A) . Acteoside inhibited glutamate-induced intracellular Ca 2+ influxes resulting in overproduction of NO and reduced formation of ROS [37] . Both PKC and Ca 2+ signaling pathways are required for histamine and leukotrienes release from mast cells as well as rodent systems [39] . We hypothesized that acteoside may have inhibitory effect on histamine release through Ca 2+ influx. For this purpose we used A21387 plus PMA to 18 stimulate KU812 cells and demonstrated histamine release inhibition effect with acteoside.
This result supported our hypothesis that acteoside may decrease histamine release from KU812 cells by inhibition of Ca 2+ influx or PKC activation.
It is believed without doubt that stimulation of mast cells with compound 48/80 initiates the activation of a signal transduction pathway, which leads to histamine release. Senyshyn et al. suggesting the complexity of its action. However, in order to reveal the mechanism of histamine release inhibition of this prescription, further studies should be performed.
Among cytokines produced by basophilic cells, TNF-α, IL-4, IL-13, and IL-5 are the key molecules. The reduction of pro-inflammatory cytokines from mast cells or basophilic cells is one of the key indicators of reduced allergic symptom [42] . With regard to TNF-α, the production is mainly regulated by Ca 2+ influx, but the release process is regulated by additional mechanisms possibly involving activation of PKC in KU812 cells. Inhibition of [Ca 2+ ]i influx is involved in the expression of cytokines in mast cells and basophilic cells [34, 43] . Our result showed that 1.0 and 10.0 µg/mL acteoside reduced TNF-α and IL-4 19 production from A23187 plus PMA stimulated KU812 cells after treatment for 16 h.
Acteoside might inhibit TNF-α and IL-4 production by decreasing the [Ca 2+ ]i level in A23187 plus PMA stimulated KU812 cells. Moreover, our results suggested that the acteoside have anti-allergic effect at the late phase. Confirmation of the effect of acteoside using FcεRI expressing mast cells or basophilic cells is necessary in the future.
In conclusions, we report for the first time that acteoside, echinacoside and cistanoside A extracted from Cistanche tubulosa can inhibit the release of β-hexosaminidase from IgE-sensitized BSA-stimulated RBL-2H3 cells. Furthermore, acteoside can inhibit the histamine release, TNF-α, and IL-4 production in a dose-dependent manner on A23187 plus PMA stimulated KU812 cells. These results suggest that acteoside could be a good candidate for the therapeutic treatment of various allergic diseases. The detailed mechanism behind the anti-allergic affect of acteoside is the subject of a future study. Fig. 1 Chemical structure of phenylethanoid glycosides extracted from Cistance tubulosa.
Legends for Figures
Acteoside: R 1 = H, R 2 = H; Echinacoside: R 1 = Glc, R 2 = H; Cistanoside A: R 1 = Glc, R 2 = CH 3 . 
